Keywords
Last Name
Institution

Scott Waldman

TitleProfessor & Chair JMC
InstitutionThomas Jefferson University
DepartmentChair SKMC
Address1020 Locust St.
Philadelphia PA 19107
Phone215-955-6086
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R55DK043805     (WALDMAN, SCOTT A.)Sep 30, 1992 - Sep 29, 1994
    NIH/NIDDK
    MOLECULAR CHARACTERIZATION OF E COLI TOXIN RECEPTORS
    Role: Principal Investigator
    T32GM008562     (WALDMAN, SCOTT A)Jul 1, 1995 - Jun 30, 2020
    NIH/NIGMS
    Clinical Pharmacology Training Program
    Role: Principal Investigator
    R01GM050290     (WALDMAN, SCOTT A.)Jul 1, 1996 - Jun 30, 2001
    NIH/NIGMS
    VITAMIN D3 25-HYDROXYLASE CHARACTERIZATION ®ULATION
    Role: Principal Investigator
    R25CA069277     (WALDMAN, SCOTT A.)Aug 1, 1997 - Mar 31, 2009
    NIH/NCI
    Short-term Training Program in Translational Cancer Rese
    Role: Principal Investigator
    R01CA075123     (WALDMAN, SCOTT A.)Jun 5, 1998 - Jan 31, 2009
    NIH/NCI
    GUANYLYL CYCLASE C AS A BI0MARKER FOR COLORECTAL CANCER
    Role: Principal Investigator
    R01HL059214     (WALDMAN, SCOTT A.)Jul 1, 1998 - Jun 30, 2002
    NIH/NHLBI
    ALLOSTERIC INHIBITION OF GUANYLYL CYCLASE BY NUCLEOTIDES
    Role: Principal Investigator
    R21CA079663     (WALDMAN, SCOTT A.)Jan 1, 1999 - Dec 31, 2002
    NIH/NCI
    GUANYLYL CYCLASE C IN BLOOD AND COLORECTAL CANCER
    Role: Principal Investigator
    K30HL004522     (WALDMAN, SCOTT A.)Sep 30, 2000 - Aug 31, 2005
    NIH/NHLBI
    TRAINING PROGRAM IN HUMAN INVESTIGATION
    Role: Principal Investigator
    K30RR022299     (WALDMAN, SCOTT A.)Sep 30, 2000 - Jun 30, 2011
    NIH/NCRR
    Training Program in Human Investigation
    Role: Principal Investigator
    R01CA095026     (WALDMAN, SCOTT A.)Aug 1, 2003 - May 31, 2010
    NIH/NCI
    Guanylyl Cyclase C in Blood and Colorectal Cancer
    Role: Principal Investigator
    RC1CA146033     (WALDMAN, SCOTT A.)Sep 30, 2009 - Aug 31, 2011
    NIH/NCI
    Occult lymph node metastases and racial disparities in colon cancer outcomes
    Role: Principal Investigator
    R01CA170533     (WALDMAN, SCOTT A.)Aug 1, 2012 - May 31, 2016
    NIH/NCI
    GUCY2C hormone signaling at the intersection of obesity and colorectal cancer(PQ1
    Role: Principal Investigator
    R01CA206026     (WALDMAN, SCOTT A)May 9, 2016 - Apr 30, 2021
    NIH/NCI
    (PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
    Role: Principal Investigator
    R01CA204481     (WALDMAN, SCOTT A)Jan 1, 2017 - Dec 31, 2021
    NIH/NCI
    Guanylin GUCY2C axis in Colorectal Cancer Initiation
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bashir B, Merlino DJ, Rappaport JA, Gnass E, Palazzo JP, Feng Y, Fearon ER, Snook AE, Waldman SA. Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated and MSI colorectal neoplasia. Hum Pathol. 2019 Feb 01. PMID: 30716341.
      View in: PubMed
    2. Waldman SA, Terzic A. Health Care Evolves From Reactive to Proactive. Clin Pharmacol Ther. 2019 Jan; 105(1):10-13. PMID: 30597564.
      View in: PubMed
    3. Rappaport JA, Waldman SA. The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Front Oncol. 2018; 8:299. PMID: 30131940.
      View in: PubMed
    4. Waldman SA. Prenatal Regeneration in Clinical Practice. Mayo Clin Proc. 2018 Jun; 93(6):673-675. PMID: 29803314.
      View in: PubMed
    5. Magee MS, Abraham TS, Baybutt TR, Flickinger JC, Ridge NA, Marszalowicz GP, Prajapati P, Hersperger AR, Waldman SA, Snook AE. Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases. Cancer Immunol Res. 2018 Apr 03. PMID: 29615399.
      View in: PubMed
    6. Waldman SA, Camilleri M. Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut. 2018 Mar 21. PMID: 29563144.
      View in: PubMed
    7. Caracciolo V, Young J, Gonzales D, Ni Y, Flowers SJ, Summer R, Waldman SA, Kim JK, Jung DY, Noh HL, Kim T, Blackshear PJ, O'Connell D, Bauer RC, Kallen CB. Myeloid-Specific Deletion of Zfp36 Protects Against Insulin Resistance and Fatty Liver in Diet-Induced Obese Mice. Am J Physiol Endocrinol Metab. 2018 Mar 06. PMID: 29509432.
      View in: PubMed
    8. Sherman W, Bartunek J, Dolatabadi D, Sanz-Ruiz R, Beleslin B, Wojakowski W, Heyndrickx G, Kimpalou JZ, Waldman SA, Laarman GJ, Seron A, Behfar A, Latere JP, Terzic A, Wijns W. First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery. JACC Cardiovasc Interv. 2018 Feb 26; 11(4):412-414. PMID: 29471956.
      View in: PubMed
    9. Waldman SA, Terzic A. Process Improvement for Maximized Therapeutic Innovation Outcome. Clin Pharmacol Ther. 2018 Jan; 103(1):8-12. PMID: 29265398.
      View in: PubMed
    10. Kraft CL, Rappaport JA, Snook AE, Pattison AM, Lynch JP, Waldman SA. GUCY2C maintains intestinal LGR5+ stem cells by opposing ER stress. Oncotarget. 2017 Nov 28; 8(61):102923-102933. PMID: 29262534.
      View in: PubMed
    11. Li P, Wuthrick E, Rappaport JA, Kraft C, Lin JE, Marszalowicz G, Snook AE, Zhan T, Hyslop TM, Waldman SA. GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome. Cancer Res. 2017 Sep 15; 77(18):5095-5106. PMID: 28916678.
      View in: PubMed
    12. Li P, Lin JE, Snook AE, Waldman SA. ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice. Toxins (Basel). 2017 Sep 12; 9(9). PMID: 28895923.
      View in: PubMed
    13. Weinberg DS, Lin JE, Foster NR, Della'Zanna G, Umar A, Seisler D, Kraft WK, Kastenberg DM, Katz LC, Limburg PJ, Waldman SA. Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. Cancer Prev Res (Phila). 2017 Jun; 10(6):345-354. PMID: 28396341.
      View in: PubMed
    14. Aka AA, Rappaport JA, Pattison AM, Sato T, Snook AE, Waldman SA. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer. Expert Rev Clin Pharmacol. 2017 May; 10(5):549-557. PMID: 28162021.
      View in: PubMed
    15. Xiang B, Baybutt TR, Berman-Booty L, Magee MS, Waldman SA, Alexeev VY, Snook AE. Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells. J Immunol. 2017 May 01; 198(9):3507-3514. PMID: 28341670.
      View in: PubMed
    16. Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, Edes I, Seferovic PM, Obradovic S, Vanderheyden M, Jagic N, Petrov I, Atar S, Halabi M, Gelev VL, Shochat MK, Kasprzak JD, Sanz-Ruiz R, Heyndrickx GR, Nyolczas N, Legrand V, Guédès A, Heyse A, Moccetti T, Fernandez-Aviles F, Jimenez-Quevedo P, Bayes-Genis A, Hernandez-Garcia JM, Ribichini F, Gruchala M, Waldman SA, Teerlink JR, Gersh BJ, Povsic TJ, Henry TD, Metra M, Hajjar RJ, Tendera M, Behfar A, Alexandre B, Seron A, Stough WG, Sherman W, Cotter G, Wijns W. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. Eur Heart J. 2017 Mar 01; 38(9):648-660. PMID: 28025189.
      View in: PubMed
    17. Chervoneva I, Freydin B, Hyslop T, Waldman SA. Modeling qRT-PCR dynamics with application to cancer biomarker quantification. Stat Methods Med Res. 2017 Jan 01; 962280216683204. PMID: 28504051.
      View in: PubMed
    18. Snook AE, Baybutt TR, Hyslop T, Waldman SA. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope. Hum Gene Ther Methods. 2016 Dec; 27(6):238-250. PMID: 27903079.
      View in: PubMed
    19. Myers RE, Wolf T, Shwae P, Hegarty S, Peiper SC, Waldman SA. A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients. BMC Cancer. 2016 Oct 03; 16(1):766. PMID: 27716119.
      View in: PubMed
    20. Pattison AM, Merlino DJ, Blomain ES, Waldman SA. Guanylyl cyclase C signaling axis and colon cancer prevention. World J Gastroenterol. 2016 Sep 28; 22(36):8070-7. PMID: 27688649.
      View in: PubMed
    21. Pattison AM, Blomain ES, Merlino DJ, Wang F, Crissey MA, Kraft CL, Rappaport JA, Snook AE, Lynch JP, Waldman SA. Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins. Infect Immun. 2016 Oct; 84(10):3083-91. PMID: 27481254.
      View in: PubMed
    22. Magee MS, Kraft CL, Abraham TS, Baybutt TR, Marszalowicz GP, Li P, Waldman SA, Snook AE. GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity. Oncoimmunology. 2016; 5(10):e1227897. PMID: 27853651.
      View in: PubMed
    23. Blomain ES, Merlino DJ, Pattison AM, Snook AE, Waldman SA. Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer. Mol Pharmacol. 2016 Sep; 90(3):199-204. PMID: 27251363.
      View in: PubMed
    24. Cantarin MP, Keith SW, Lin Z, Doria C, Frank AM, Maley WR, Ramirez C, Lallas CD, Shah A, Waldman SA, Falkner B. Association of Inflammation prior to Kidney Transplantation with Post-Transplant Diabetes Mellitus. Cardiorenal Med. 2016 Aug; 6(4):289-300. PMID: 27648010.
      View in: PubMed
    25. Blomain ES, Pattison AM, Waldman SA. GUCY2C ligand replacement to prevent colorectal cancer. Cancer Biol Ther. 2016 Jul 2; 17(7):713-8. PMID: 27104761.
      View in: PubMed
    26. Blomain ES, Waldman SA. Does obesity promote the development of colorectal cancer? Expert Rev Anticancer Ther. 2016 May; 16(5):465-7. PMID: 26943700.
      View in: PubMed
    27. Lin JE, Colon-Gonzalez F, Blomain E, Kim GW, Aing A, Stoecker B, Rock J, Snook AE, Zhan T, Hyslop TM, Tomczak M, Blumberg RS, Waldman SA. Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis. Cancer Res. 2016 Jan 15; 76(2):339-46. PMID: 26773096.
      View in: PubMed
    28. Waldman SA. Editorial (Thematic Issue: Ferid Murad, at 80: A Legacy of Science, Medicine, and Mentorship). Curr Med Chem. 2016; 23(24):2556-2558. PMID: 27776470.
      View in: PubMed
    29. Krishnan V, Xu X, Kelly D, Snook A, Waldman SA, Mason RW, Jia X, Rajasekaran AK. CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia. Mol Pharm. 2015 Jun 1; 12(6):2101-11. PMID: 25898125.
      View in: PubMed
    30. Waldman SA, Terzic A. Companion diagnostics at the intersection of personalized medicine and healthcare delivery. Biomark Med. 2015 Jan; 9(1):1-3. PMID: 25605449.
      View in: PubMed
    31. Rodriguez E, Sakowski L, Hobson GM, Armani MH, Kreiger PA, Zhu Y, Waldman SA, Shaffer TH. Plp1 gene duplication inhibits airway responsiveness and induces lung inflammation. Pulm Pharmacol Ther. 2015 Feb; 30:22-31. PMID: 25445931.
      View in: PubMed
    32. Marszalowicz GP, Snook AE, Magee MS, Merlino D, Berman-Booty LD, Waldman SA. GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer. Oncotarget. 2014 Oct 15; 5(19):9460-71. PMID: 25294806.
      View in: PubMed
    33. Wilson C, Lin JE, Li P, Snook AE, Gong J, Sato T, Liu C, Girondo MA, Rui H, Hyslop T, Waldman SA. The Paracrine Hormone for the GUCY2C Tumor Suppressor, Guanylin, Is Universally Lost in Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2328-37. PMID: 25304930.
      View in: PubMed
    34. Rodriguez E, Barthold JS, Kreiger PA, Armani MH, Wang J, Michelini KA, Wolfson MR, Boyce R, Barone CA, Zhu Y, Waldman SA, Shaffer TH. The orl rat is more responsive to methacholine challenge than wild type. Pulm Pharmacol Ther. 2014 Dec; 29(2):199-208. PMID: 25218882.
      View in: PubMed
    35. Witek ME, Snook AE, Lin JE, Blomain ES, Xiang B, Magee M, Waldman SA. A Novel CDX2 Isoform Regulates Alternative Splicing. PLoS One. 2014; 9(8):e104293. PMID: 25101906.
      View in: PubMed
    36. Martinez Cantarin MP, Keith SW, Waldman SA, Falkner B. Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease. Nephrol Dial Transplant. 2014 Dec; 29(12):2268-77. PMID: 25049200.
      View in: PubMed
    37. Merlino DJ, Blomain ES, Aing AS, Waldman SA. Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy. J Clin Med. 2014; 3(3):763-94. PMID: 26237477.
      View in: PubMed
    38. Snook AE, Magee MS, Schulz S, Waldman SA. Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy. Eur J Immunol. 2014 Jul; 44(7):1956-66. PMID: 24771148.
      View in: PubMed
    39. Witek M, Blomain ES, Magee MS, Xiang B, Waldman SA, Snook AE. Tumor Radiation Therapy Creates Therapeutic Vaccine Responses to the Colorectal Cancer Antigen GUCY2C. Int J Radiat Oncol Biol Phys. 2014 Apr 1; 88(5):1188-95. PMID: 24661671.
      View in: PubMed
    40. Nofziger C, Papaluca M, Terzic A, Waldman S, Paulmichl M. Policies to aid the adoption of personalized medicine. Nat Rev Drug Discov. 2014 Feb 28; 13(3):159-60. PMID: 24577385.
      View in: PubMed
    41. Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A. Reply: The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE). J Am Coll Cardiol. 2013 Dec 24; 62(25):2454-6. PMID: 24355591.
      View in: PubMed
    42. Ganesh SK, Arnett DK, Assimes TL, Basson CT, Chakravarti A, Ellinor PT, Engler MB, Goldmuntz E, Herrington DM, Hershberger RE, Hong Y, Johnson JA, Kittner SJ, McDermott DA, Meschia JF, Mestroni L, O'Donnell CJ, Psaty BM, Vasan RS, Ruel M, Shen WK, Terzic A, Waldman SA. Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the american heart association. Circulation. 2013 Dec 24; 128(25):2813-51. PMID: 24297835.
      View in: PubMed
    43. Gibbons AV, Lin JE, Kim GW, Marszalowicz GP, Li P, Stoecker BA, Blomain ES, Rattan S, Snook AE, Schulz S, Waldman SA. Intestinal GUCY2C Prevents TGF-ß Secretion Coordinating Desmoplasia and Hyperproliferation in Colorectal Cancer. Cancer Res. 2013 Nov 15; 73(22):6654-66. PMID: 24085786.
      View in: PubMed
    44. Blomain ES, Lin JE, Kraft CL, Trela UT, Rock JM, Aing AS, Snook AE, Waldman SA. Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis. Expert Rev Clin Pharmacol. 2013 Sep; 6(5):557-64. PMID: 23971873.
      View in: PubMed
    45. Xiang B, Snook AE, Magee MS, Waldman SA. Colorectal cancer immunotherapy. Discov Med. 2013 May; 15(84):301-8. PMID: 23725603.
      View in: PubMed
    46. Kim GW, Lin JE, Blomain ES, Waldman SA. New advances in models and strategies for developing anti-obesity drugs. Expert Opin Drug Discov. 2013 Jun; 8(6):655-71. PMID: 23621300.
      View in: PubMed
    47. Blomain ES, Dirhan DA, Valentino MA, Kim GW, Waldman SA. Mechanisms of Weight Regain following Weight Loss. ISRN Obes. 2013; 2013:210524. PMID: 24533218.
      View in: PubMed
    48. Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A. Cardiopoietic Stem Cell Therapy in Heart Failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics. J Am Coll Cardiol. 2013 Jun 11; 61(23):2329-38. PMID: 23583246.
      View in: PubMed
    49. Avital I, Summers TA, Steele SR, Waldman S, Nissan A, Bilchik AJ, Protic M, Man YG, Brücher BL, Stojadinovic A. Colorectal cancer stem cells as biomarkers: Where it all starts? J Surg Oncol. 2013 Jun; 107(8):791-3. PMID: 23512573.
      View in: PubMed
    50. Avital I, Langan RC, Summers TA, Steele SR, Waldman SA, Backman V, Yee J, Nissan A, Young P, Womeldorph C, Mancusco P, Mueller R, Noto K, Grundfest W, Bilchik AJ, Protic M, Daumer M, Eberhardt J, Man YG, Brücher BL, Stojadinovic A. Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions. J Cancer. 2013; 4(3):172-92. PMID: 23459409.
      View in: PubMed
    51. Hyslop T, Waldman SA. Molecular staging of node negative patients with colorectal cancer. J Cancer. 2013; 4(3):193-9. PMID: 23459453.
      View in: PubMed
    52. Snook AE, Waldman SA. Advances in cancer immunotherapy. Discov Med. 2013 Feb; 15(81):120-5. PMID: 23449114.
      View in: PubMed
    53. Waldman SA, Terzic A. Translational medicine individualizes healthcare discovery, development and delivery. Biomark Med. 2013 Feb; 7(1):1-3. PMID: 23387479.
      View in: PubMed
    54. Magee MS, Snook AE, Marszalowicz GP, Waldman SA. Immunotherapeutic strategies to target prognostic and predictive markers of cancer. Biomark Med. 2013 Feb; 7(1):23-35. PMID: 23387482.
      View in: PubMed
    55. Hyslop T, Waldman SA. Guanylyl cyclase C as a biomarker in colorectal cancer. Biomark Med. 2013 Feb; 7(1):159-67. PMID: 23387497.
      View in: PubMed
    56. Kim GW, Lin JE, Waldman SA. GUCY2C: at the intersection of obesity and cancer. Trends Endocrinol Metab. 2013 Apr; 24(4):165-73. PMID: 23375388.
      View in: PubMed
    57. Martinez Cantarin MP, Waldman SA, Doria C, Frank AM, Maley WR, Ramirez CB, Keith SW, Falkner B. The adipose tissue production of adiponectin is increased in end-stage renal disease. Kidney Int. 2013 Mar; 83(3):487-94. PMID: 23283133.
      View in: PubMed
    58. Krishnan V, Xu X, Barwe SP, Yang X, Czymmek K, Waldman SA, Mason RW, Jia X, Rajasekaran AK. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine. Mol Pharm. 2013 Jun 3; 10(6):2199-210. PMID: 23194373.
      View in: PubMed
    59. Colon-Gonzalez F, Kim GW, Lin JE, Valentino MA, Waldman SA. Obesity pharmacotherapy: What is next? Mol Aspects Med. 2013 Feb; 34(1):71-83. PMID: 23103610.
      View in: PubMed
    60. Gong JP, Schulz S, Hyslop T, Waldman SA. GUCY2C molecular staging personalizes colorectal cancer patient management. Biomark Med. 2012 Jun; 6(3):339-48. PMID: 22731908.
      View in: PubMed
    61. Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA. Molecular staging individualizing cancer management. J Surg Oncol. 2012 Apr 1; 105(5):468-74. PMID: 22441898.
      View in: PubMed
    62. Waldman SA, Terzic A. The value proposition of molecular medicine. Clin Transl Sci. 2012 Feb; 5(1):108-10. PMID: 22376267.
      View in: PubMed
    63. Lin JE, Snook AE, Li P, Stoecker BA, Kim GW, Magee MS, Garcia AV, Valentino MA, Hyslop T, Schulz S, Waldman SA. GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity. PLoS One. 2012; 7(2):e31686. PMID: 22384056.
      View in: PubMed
    64. Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer. J Surg Oncol. 2012 Jul 1; 106(1):24-30. PMID: 22252429.
      View in: PubMed
    65. Yusuf D, Butland SL, Swanson MI, Bolotin E, Ticoll A, Cheung WA, Zhang XY, Dickman CT, Fulton DL, Lim JS, Schnabl JM, Ramos OH, Vasseur-Cognet M, de Leeuw CN, Simpson EM, Ryffel GU, Lam EW, Kist R, Wilson MS, Marco-Ferreres R, Brosens JJ, Beccari LL, Bovolenta P, Benayoun BA, Monteiro LJ, Schwenen HD, Grontved L, Wederell E, Mandrup S, Veitia RA, Chakravarthy H, Hoodless PA, Mancarelli MM, Torbett BE, Banham AH, Reddy SP, Cullum RL, Liedtke M, Tschan MP, Vaz M, Rizzino A, Zannini M, Frietze S, Farnham PJ, Eijkelenboom A, Brown PJ, Laperrière D, Leprince D, de Cristofaro T, Prince KL, Putker M, del Peso L, Camenisch G, Wenger RH, Mikula M, Rozendaal M, Mader S, Ostrowski J, Rhodes SJ, Van Rechem C, Boulay G, Olechnowicz SW, Breslin MB, Lan MS, Nanan KK, Wegner M, Hou J, Mullen RD, Colvin SC, Noy PJ, Webb CF, Witek ME, Ferrell S, Daniel JM, Park J, Waldman SA, Peet DJ, Taggart M, Jayaraman PS, Karrich JJ, Blom B, Vesuna F, O'Geen H, Sun Y, Gronostajski RM, Woodcroft MW, Hough MR, Chen E, Europe-Finner GN, Karolczak-Bayatti M, Bailey J, Hankinson O, Raman V, LeBrun DP, Biswal S, Harvey CJ, DeBruyne JP, Hogenesch JB, Hevner RF, Héligon C, Luo XM, Blank MC, Millen KJ, Sharlin DS, Forrest D, Dahlman-Wright K, Zhao C, Mishima Y, Sinha S, Chakrabarti R, Portales-Casamar E, Sladek FM, Bradley PH, Wasserman WW. The transcription factor encyclopedia. Genome Biol. 2012; 13(3):R24. PMID: 22458515.
      View in: PubMed
    66. Waldman SA, Terzic A. Patient-centric clinical pharmacology advances the path to personalized medicine. Biomark Med. 2011 Dec; 5(6):697-700. PMID: 22103605.
      View in: PubMed
    67. Snook AE, Magee MS, Waldman SA. GUCY2C-targeted cancer immunotherapy: past, present and future. Immunol Res. 2011 Dec; 51(2-3):161-9. PMID: 22038530.
      View in: PubMed
    68. Snook AE, Magee MS, Marszalowicz GP, Schulz S, Waldman SA. Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C. Cancer Immunol Immunother. 2012 May; 61(5):713-23. PMID: 22057677.
      View in: PubMed
    69. Waldman SA, Terzic A. Widening the path to personalized medicine. Clin Transl Sci. 2011 Oct; 4(5):392-4. PMID: 22029815.
      View in: PubMed
    70. Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes. Cancer. 2012 May 1; 118(9):2532-40. PMID: 21887684.
      View in: PubMed
    71. Valentino MA, Lin JE, Snook AE, Li P, Kim GW, Marszalowicz G, Magee MS, Hyslop T, Schulz S, Waldman SA. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice. J Clin Invest. 2011 Sep; 121(9):3578-88. PMID: 21865642.
      View in: PubMed
    72. Crist RC, Roth JJ, Waldman SA, Buchberg AM. A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer. PLoS One. 2011; 6(8):e23665. PMID: 21858198.
      View in: PubMed
    73. Zuzga DS, Pelta-Heller J, Li P, Bombonati A, Waldman SA, Pitari GM. Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer. Int J Cancer. 2012 Jun 1; 130(11):2539-48. PMID: 21702043.
      View in: PubMed
    74. Terzic A, Waldman S. Chronic diseases: the emerging pandemic. Clin Transl Sci. 2011 Jun; 4(3):225-6. PMID: 21707955.
      View in: PubMed
    75. Waldman SA, Terzic A. Clinical pharmacology at the core of translational science. Expert Rev Clin Pharmacol. 2011 May; 4(3):303-5. PMID: 22114776.
      View in: PubMed
    76. Goldberg BB, Merton DA, Liu JB, Forsberg F, Zhang K, Thakur M, Schulz S, Schanche R, Murphy GF, Waldman SA. Contrast-enhanced ultrasound imaging of sentinel lymph nodes after peritumoral administration of Sonazoid in a melanoma tumor animal model. J Ultrasound Med. 2011 Apr; 30(4):441-53. PMID: 21460143.
      View in: PubMed
    77. Waldman SA, Terzic A. Bionic technologies transforming the science of healthcare delivery. Clin Transl Sci. 2011 Apr; 4(2):84-6. PMID: 21463492.
      View in: PubMed
    78. Kim GW, Lin JE, Valentino MA, Colon-Gonzalez F, Waldman SA. Regulation of appetite to treat obesity. Expert Rev Clin Pharmacol. 2011 Mar; 4(2):243-59. PMID: 21666781.
      View in: PubMed
    79. Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer. Clin Cancer Res. 2011 May 15; 17(10):3293-303. PMID: 21307149.
      View in: PubMed
    80. Waldman SA, Terzic A. Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise. Clin Transl Sci. 2011 Feb; 4(1):69-71. PMID: 21348959.
      View in: PubMed
    81. Terzic A, Waldman SA. Translational medicine: path to personalized and public health. Biomark Med. 2010 Dec; 4(6):787-90. PMID: 21133696.
      View in: PubMed
    82. Waldman SA, Terzic A. Clinical and translational science: from bench-bedside to global village. Clin Transl Sci. 2010 Oct; 3(5):254-7. PMID: 20973923.
      View in: PubMed
    83. Valentino MA, Colon-Gonzalez F, Lin JE, Waldman SA. Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity. Expert Rev Endocrinol Metab. 2010 Sep 1; 5(5):765-783. PMID: 21297878.
      View in: PubMed
    84. Li P, Waldman SA. Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis. Cancer Biol Ther. 2010 Aug; 10(3):211-8. PMID: 20592492.
      View in: PubMed
    85. Lin JE, Valentino M, Marszalowicz G, Magee MS, Li P, Snook AE, Stoecker BA, Chang C, Waldman SA. Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics. Toxins (Basel). 2010 Aug; 2(8):2028-54. PMID: 22069671.
      View in: PubMed
    86. Waldman SA, Terzic A. Molecular therapy drives patient-centric health care paradigms. Clin Transl Sci. 2010 Aug; 3(4):170-1. PMID: 20718817.
      View in: PubMed
    87. Valentino MA, Terzic A, Waldman SA. Sizing up pharmacotherapy for obesity. Clin Transl Sci. 2010 Jun; 3(3):123-5. PMID: 20590683.
      View in: PubMed
    88. Chervoneva I, Li Y, Schulz S, Croker S, Wilson C, Waldman SA, Hyslop T. Selection of optimal reference genes for normalization in quantitative RT-PCR. BMC Bioinformatics. 2010; 11:253. PMID: 20470420.
      View in: PubMed
    89. Bharucha AE, Waldman SA. Taking a lesson from microbial diarrheagenesis in the management of chronic constipation. Gastroenterology. 2010 Mar; 138(3):813-7. PMID: 20114092.
      View in: PubMed
    90. Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA. Molecular staging estimates occult tumor burden in colorectal cancer. Adv Clin Chem. 2010; 52:19-39. PMID: 21275338.
      View in: PubMed
    91. Waldman SA, Kraft WK, Nelson TJ, Terzic A. Clinical pharmacology: a paradigm for individualized medicine. Biomark Med. 2009 Dec; 3(6):679-84. PMID: 20477706.
      View in: PubMed
    92. Waldman SA, Kraft WK, Nelson TJ, Terzic A. Experimental therapeutics: a paradigm for personalized medicine. Clin Transl Sci. 2009 Dec; 2(6):436-8. PMID: 20443936.
      View in: PubMed
    93. Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA. GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients. Expert Rev Mol Diagn. 2009 Nov; 9(8):777-85. PMID: 19895223.
      View in: PubMed
    94. Park JY, Kirn TJ, Artis D, Waldman SA, Kricka LJ. Chemiluminescence-based detection of gastrointestinal malignancies. Luminescence. 2010 Nov-Dec; 25(6):463-5. PMID: 19827005.
      View in: PubMed
    95. Winn B, Tavares R, Matoso A, Noble L, Fanion J, Waldman SA, Resnick MB. Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomas. Hum Pathol. 2010 Jan; 41(1):123-8. PMID: 19800103.
      View in: PubMed
    96. Lin JE, Li P, Snook AE, Schulz S, Dasgupta A, Hyslop TM, Gibbons AV, Marszlowicz G, Pitari GM, Waldman SA. The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling. Gastroenterology. 2010 Jan; 138(1):241-54. PMID: 19737566.
      View in: PubMed
    97. Ciocca V, Bombonati A, Palazzo JP, Schulz S, Waldman SA. Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasms. Histopathology. 2009 Aug; 55(2):182-8. PMID: 19694825.
      View in: PubMed
    98. Gong L, Debruyne PR, Witek M, Nielsen K, Snook A, Lin JE, Bombonati A, Palazzo J, Schulz S, Waldman SA. Bile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis. Clin Transl Sci. 2009 Aug; 2(4):286-93. PMID: 20443907.
      View in: PubMed
    99. Li P, Lin JE, Marszlowicz GP, Valentino MA, Chang C, Schulz S, Pitari GM, Waldman SA. GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome? Drug News Perspect. 2009 Jul-Aug; 22(6):313-8. PMID: 19771320.
      View in: PubMed
    100. Waldman SA, Terzic A. Applications of microRNA in cancer: Exploring the advantages of miRNA. Clin Transl Sci. 2009 Jun; 2(3):248-9. PMID: 20443899.
      View in: PubMed
    101. Lin JE, Li P, Pitari GM, Schulz S, Waldman SA. Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target. Future Oncol. 2009 May; 5(4):509-22. PMID: 19450179.
      View in: PubMed
    102. Snook AE, Li P, Stafford BJ, Faul EJ, Huang L, Birbe RC, Bombonati A, Schulz S, Schnell MJ, Eisenlohr LC, Waldman SA. Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease. Cancer Res. 2009 Apr 15; 69(8):3537-44. PMID: 19351847.
      View in: PubMed
    103. Waldman SA, Terzic A. Translational medicine in the era of health care reform. Clin Transl Sci. 2009 Apr; 2(2):96-7. PMID: 20443877.
      View in: PubMed
    104. Lubbe WJ, Zuzga DS, Zhou Z, Fu W, Pelta-Heller J, Muschel RJ, Waldman SA, Pitari GM. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. Cancer Res. 2009 Apr 15; 69(8):3529-36. PMID: 19336567.
      View in: PubMed
    105. Waldman SA, Terzic A. A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer. FEBS J. 2009 Apr; 276(8):2157-64. PMID: 19250312.
      View in: PubMed
    106. Waldman SA, Hyslop T, Schulz S, Barkun A, Nielsen K, Haaf J, Bonaccorso C, Li Y, Weinberg DS. Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer. JAMA. 2009 Feb 18; 301(7):745-52. PMID: 19224751.
      View in: PubMed
    107. Waldman SA, Terzic A. Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy. Clin Transl Sci. 2009 Feb; 2(1):6-8. PMID: 20443861.
      View in: PubMed
    108. Chang C, Marszlowicz G, Waldman Z, Li P, Snook AE, Lin JE, Schulz S, Waldman SA. Guanylyl cyclase C as a biomarker for targeted imaging and therapy of metastatic colorectal cancer. Biomark Med. 2009 Feb; 3(1):33-45. PMID: 20477494.
      View in: PubMed
    109. Waldman SA. Transitioning biomarkers into the clinic. Expert Rev Clin Pharmacol. 2009 Jan; 2(1):9-13. PMID: 24422768.
      View in: PubMed
    110. Snook AE, Waldman SA. CANCER MUCOSA ANTIGENS A NOVEL PARADIGM IN CANCER IMMUNOTHERAPEUTICS. Bioforum Eur. 2009; 3:14-16. PMID: 26855637.
      View in: PubMed
    111. Snook AE, Huang L, Schulz S, Eisenlohr LC, Waldman SA. Cytokine adjuvanation of therapeutic anti-tumor immunity targeted to cancer mucosa antigens. Clin Transl Sci. 2008 Dec; 1(3):263-4. PMID: 19956776.
      View in: PubMed
    112. Waldman SA, Terzic A. The roadmap to personalized medicine. Clin Transl Sci. 2008 Sep; 1(2):93. PMID: 20443827.
      View in: PubMed
    113. Li P, Schulz S, Pitari GM, Waldman SA. Sex modulates intestinal transformation by the tumor-suppressor GCC. Clin Transl Sci. 2008 Sep; 1(2):146-50. PMID: 20443837.
      View in: PubMed
    114. Li P, Schulz S, Pitari GM, Waldman SA. Sex modulates intestinal transformation by the tumor-suppressor GCC. Clin Transl Sci. 2008 Sep; 1(2):150. PMID: 20443838.
      View in: PubMed
    115. Snook AE, Stafford BJ, Li P, Tan G, Huang L, Birbe R, Schulz S, Schnell MJ, Thakur M, Rothstein JL, Eisenlohr LC, Waldman SA. Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity. J Natl Cancer Inst. 2008 Jul 2; 100(13):950-61. PMID: 18577748.
      View in: PubMed
    116. Pitari GM, Lin JE, Shah FJ, Lubbe WJ, Zuzga DS, Li P, Schulz S, Waldman SA. Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells. Carcinogenesis. 2008 Aug; 29(8):1601-7. PMID: 18566015.
      View in: PubMed
    117. Waldman SA, Terzic A. MicroRNA signatures as diagnostic and therapeutic targets. Clin Chem. 2008 Jun; 54(6):943-4. PMID: 18509012.
      View in: PubMed
    118. Waldman SA, Terzic A. Clinical and translational sciences: at the intersection of molecular and individualized medicine. Clin Transl Sci. 2008 May; 1(1):6-8. PMID: 20443812.
      View in: PubMed
    119. Plesa G, Snook AE, Waldman SA, Eisenlohr LC. Derivation and fluidity of acutely induced dysfunctional CD8+ T cells. J Immunol. 2008 Apr 15; 180(8):5300-8. PMID: 18390711.
      View in: PubMed
    120. Waldman SA, Terzic A. Therapeutic burden in cancer revealed by molecular staging. Biomark Med. 2008 Feb; 2(1):1-3. PMID: 20477357.
      View in: PubMed
    121. Tian X, Michal AM, Li P, Wolfe HR, Waldman SA, Wickstrom E. STa peptide analogs for probing guanylyl cyclase C. Biopolymers. 2008; 90(5):713-23. PMID: 18615494.
      View in: PubMed
    122. Kraft WK, Waldman SA. Bridging the therapeutic continuum of drug development, regulation and use. Expert Rev Clin Pharmacol. 2008 Jan; 1(1):1-3. PMID: 24410503.
      View in: PubMed
    123. Larusso J, Waldman SA, Kraft WK. Aprepitant for the prevention of nausea and vomiting associated with chemotherapy and postoperative recovery. Expert Rev Clin Pharmacol. 2008 Jan; 1(1):27-37. PMID: 24410507.
      View in: PubMed
    124. Chervoneva I, Li Y, Iglewicz B, Waldman S, Hyslop T. Relative quantification based on logistic models for individual polymerase chain reactions. Stat Med. 2007 Dec 30; 26(30):5596-611. PMID: 17968873.
      View in: PubMed
    125. Li P, Lin JE, Chervoneva I, Schulz S, Waldman SA, Pitari GM. Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine. Am J Pathol. 2007 Dec; 171(6):1847-58. PMID: 17974601.
      View in: PubMed
    126. Terzic A, Moore RL, Waldman SA. Acquired and innate cardioprotection. J Appl Physiol. 2007 Oct; 103(4):1436-7. PMID: 17690193.
      View in: PubMed
    127. Li P, Schulz S, Bombonati A, Palazzo JP, Hyslop TM, Xu Y, Baran AA, Siracusa LD, Pitari GM, Waldman SA. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity. Gastroenterology. 2007 Aug; 133(2):599-607. PMID: 17681179.
      View in: PubMed
    128. Waldman S, Terzic A. Targeted diagnostics and therapeutics for individualized patient management. Biomark Med. 2007 Jun; 1(1):3-8. PMID: 20477454.
      View in: PubMed
    129. Snook AE, Stafford BJ, Eisenlohr LC, Rothstein JL, Waldman SA. Mucosally restricted antigens as novel immunological targets for antitumor therapy. Biomark Med. 2007 Jun; 1(1):187-202. PMID: 20477468.
      View in: PubMed
    130. Waldman SA, Terzic A. Translating MicroRNA discovery into clinical biomarkers in cancer. JAMA. 2007 May 2; 297(17):1923-5. PMID: 17473304.
      View in: PubMed
    131. Gong L, Greenberg HE, Perhach JL, Waldman SA, Kraft WK. The pharmacokinetics of taurolidine metabolites in healthy volunteers. J Clin Pharmacol. 2007 Jun; 47(6):697-703. PMID: 17395893.
      View in: PubMed
    132. Fortina P, Kricka LJ, Graves DJ, Park J, Hyslop T, Tam F, Halas N, Surrey S, Waldman SA. Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Trends Biotechnol. 2007 Apr; 25(4):145-52. PMID: 17316852.
      View in: PubMed
    133. Wilson CL, Schultz S, Waldman SA. Where medicine, business, and public policy intersect. Biotechnol Healthc. 2007 Feb; 4(1):33-42. PMID: 23397413.
      View in: PubMed
    134. de Godoy MA, Patel CA, Waldman SA, Katsuki M, Regan RF, Rattan S. H-ras inhibits RhoA/ROCK leading to a decrease in the basal tone in the internal anal sphincter. Gastroenterology. 2007 Apr; 132(4):1401-9. PMID: 17408635.
      View in: PubMed
    135. Waldman SA, Fortina P, Surrey S, Hyslop T, Kricka LJ, Graves DJ. Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells. Future Oncol. 2006 Dec; 2(6):705-16. PMID: 17155897.
      View in: PubMed
    136. Schulz S, Hyslop T, Haaf J, Bonaccorso C, Nielsen K, Witek ME, Birbe R, Palazzo J, Weinberg D, Waldman SA. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer. Clin Cancer Res. 2006 Aug 1; 12(15):4545-52. PMID: 16899600.
      View in: PubMed
    137. Pitari GM, Li T, Baksh RI, Waldman SA. Exisulind and guanylyl cyclase C induce distinct antineoplastic signaling mechanisms in human colon cancer cells. Mol Cancer Ther. 2006 May; 5(5):1190-6. PMID: 16731751.
      View in: PubMed
    138. Debruyne PR, Witek M, Gong L, Birbe R, Chervoneva I, Jin T, Domon-Cell C, Palazzo JP, Freund JN, Li P, Pitari GM, Schulz S, Waldman SA. Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells. Gastroenterology. 2006 Apr; 130(4):1191-206. PMID: 16618413.
      View in: PubMed
    139. Lubbe WJ, Zhou ZY, Fu W, Zuzga D, Schulz S, Fridman R, Muschel RJ, Waldman SA, Pitari GM. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer. Clin Cancer Res. 2006 Mar 15; 12(6):1876-82. PMID: 16551873.
      View in: PubMed
    140. Majumdar AK, Howard L, Goldberg MR, Hickey L, Constanzer M, Rothenberg PL, Crumley TM, Panebianco D, Bradstreet TE, Bergman AJ, Waldman SA, Greenberg HE, Butler K, Knops A, De Lepeleire I, Michiels N, Petty KJ. Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers. J Clin Pharmacol. 2006 Mar; 46(3):291-300. PMID: 16490805.
      View in: PubMed
    141. Witek ME, Nielsen K, Walters R, Hyslop T, Palazzo J, Schulz S, Waldman SA. The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas. Clin Cancer Res. 2005 Dec 15; 11(24 Pt 1):8549-56. PMID: 16361536.
      View in: PubMed
    142. Pitari GM, Baksh RI, Harris DM, Li P, Kazerounian S, Waldman SA. Interruption of homologous desensitization in cyclic guanosine 3',5'-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins. Cancer Res. 2005 Dec 1; 65(23):11129-35. PMID: 16322263.
      View in: PubMed
    143. Chervoneva I, Hyslop T, Iglewicz B, Johns L, Wolfe HR, Schulz S, Leong E, Waldman S. Statistical algorithm for assuring similar efficiency in standards and samples for absolute quantification by real-time reverse transcription polymerase chain reaction. Anal Biochem. 2006 Jan 15; 348(2):198-208. PMID: 16336939.
      View in: PubMed
    144. Frick GS, Pitari GM, Weinberg DS, Hyslop T, Schulz S, Waldman SA. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer. Expert Rev Mol Diagn. 2005 Sep; 5(5):701-13. PMID: 16149873.
      View in: PubMed
    145. Kazerounian S, Pitari GM, Shah FJ, Frick GS, Madesh M, Ruiz-Stewart I, Schulz S, Hajnóczky G, Waldman SA. Proliferative signaling by store-operated calcium channels opposes colon cancer cell cytostasis induced by bacterial enterotoxins. J Pharmacol Exp Ther. 2005 Sep; 314(3):1013-22. PMID: 15937149.
      View in: PubMed
    146. Birbe R, Palazzo JP, Walters R, Weinberg D, Schulz S, Waldman SA. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract. Hum Pathol. 2005 Feb; 36(2):170-9. PMID: 15754294.
      View in: PubMed
    147. Stone JA, Migoya EM, Hickey L, Winchell GA, Deutsch PJ, Ghosh K, Freeman A, Bi S, Desai R, Dilzer SC, Lasseter KC, Kraft WK, Greenberg H, Waldman SA. Potential for interactions between caspofungin and nelfinavir or rifampin. Antimicrob Agents Chemother. 2004 Nov; 48(11):4306-14. PMID: 15504857.
      View in: PubMed
    148. Waldman SA. Markers of cell cycle-mediated drug resistance and prognosis of patients receiving preoperative combined modality therapy for rectal cancer. Ann Surg Oncol. 2004 Nov; 11(11):949-50. PMID: 15525820.
      View in: PubMed
    149. Agrawal NG, Matthews CZ, Mazenko RS, Woolf EJ, Porras AG, Chen X, Miller JL, Michiels N, Wehling M, Schultz A, Gottlieb AB, Kraft WK, Greenberg HE, Waldman SA, Curtis SP, Gottesdiener KM. The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity. J Clin Pharmacol. 2004 Oct; 44(10):1125-31. PMID: 15342613.
      View in: PubMed
    150. Kraft WK, McCrea JB, Winchell GA, Carides A, Lowry R, Woolf EJ, Kusma SE, Deutsch PJ, Greenberg HE, Waldman SA. Indinavir and rifabutin drug interactions in healthy volunteers. J Clin Pharmacol. 2004 Mar; 44(3):305-13. PMID: 14973305.
      View in: PubMed
    151. Tiyyagura SR, Kazerounian S, Schulz S, Waldman SA, Pitari GM. Reciprocal regulation and integration of signaling by intracellular calcium and cyclic GMP. Vitam Horm. 2004; 69:69-94. PMID: 15196879.
      View in: PubMed
    152. Gong L, Pitari GM, Schulz S, Waldman SA. Nitric oxide signaling: systems integration of oxygen balance in defense of cell integrity. Curr Opin Hematol. 2004 Jan; 11(1):7-14. PMID: 14676622.
      View in: PubMed
    153. Kraft WK, Steiger B, Beussink D, Quiring JN, Fitzgerald N, Greenberg HE, Waldman SA. The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers. J Clin Pharmacol. 2004 Jan; 44(1):67-72. PMID: 14681343.
      View in: PubMed
    154. Lasseter KC, Dilzer SC, Vargas R, Waldman S, Noveck RJ. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study. Clin Pharmacokinet. 2004; 43(2):121-9. PMID: 14748620.
      View in: PubMed
    155. Veronese ML, Gillen LP, Dorval EP, Hauck WW, Waldman SA, Greenberg HE. Effect of mibefradil on CYP3A4 in vivo. J Clin Pharmacol. 2003 Oct; 43(10):1091-100. PMID: 14517191.
      View in: PubMed
    156. Burke J, Kraft WK, Greenberg HE, Gleave M, Pitari GM, VanBuren S, Wagner JA, Waldman SA. Relationship of arachidonic acid concentration to cyclooxygenase-dependent human platelet aggregation. J Clin Pharmacol. 2003 Sep; 43(9):983-9. PMID: 12971030.
      View in: PubMed
    157. Veronese ML, Gillen LP, Burke JP, Dorval EP, Hauck WW, Pequignot E, Waldman SA, Greenberg HE. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. J Clin Pharmacol. 2003 Aug; 43(8):831-9. PMID: 12953340.
      View in: PubMed
    158. Debruyne PR, Waldman SA, Schulz S. Pathological staging and therapy of oesophageal and gastric cancer. Expert Opin Pharmacother. 2003 Jul; 4(7):1083-96. PMID: 12831335.
      View in: PubMed
    159. Dallob A, Hawkey CJ, Greenberg H, Wight N, De Schepper P, Waldman S, Wong P, DeTora L, Gertz B, Agrawal N, Wagner J, Gottesdiener K. Characterization of etoricoxib, a novel, selective COX-2 inhibitor. J Clin Pharmacol. 2003 Jun; 43(6):573-85. PMID: 12817520.
      View in: PubMed
    160. Blum RA, Majumdar A, McCrea J, Busillo J, Orlowski LH, Panebianco D, Hesney M, Petty KJ, Goldberg MR, Murphy MG, Gottesdiener KM, Hustad CM, Lates C, Kraft WK, Van Buren S, Waldman SA, Greenberg HE. Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects. Clin Ther. 2003 May; 25(5):1407-19. PMID: 12867217.
      View in: PubMed
    161. Musson DG, Majumdar A, Birk K, Holland S, Wickersham P, Li SX, Mistry G, Fisher A, Waldman S, Greenberg H, Deutsch P, Rogers JD. Pharmacokinetics of intramuscularly administered ertapenem. Antimicrob Agents Chemother. 2003 May; 47(5):1732-5. PMID: 12709348.
      View in: PubMed
    162. Casale TB, Blaiss MS, Gelfand E, Gilmore T, Harvey PD, Hindmarch I, Simons FE, Spangler DL, Szefler SJ, Terndrup TE, Waldman SA, Weiler J, Wong DF. First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol. 2003 May; 111(5):S835-42. PMID: 12743547.
      View in: PubMed
    163. Rathi S, Kazerounian S, Banwait K, Schulz S, Waldman SA, Rattan S. Functional and molecular characterization of beta-adrenoceptors in the internal anal sphincter. J Pharmacol Exp Ther. 2003 May; 305(2):615-24. PMID: 12606629.
      View in: PubMed
    164. Park J, Schulz S, Haaf J, Kairys JC, Waldman SA. Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach. Cancer Epidemiol Biomarkers Prev. 2002 Aug; 11(8):739-44. PMID: 12163327.
      View in: PubMed
    165. Waldman SA. Does potency predict clinical efficacy? Illustration through an antihistamine model. Ann Allergy Asthma Immunol. 2002 Jul; 89(1):7-11; quiz 11-2, 77. PMID: 12141724.
      View in: PubMed
    166. Wolfe HR, Waldman SA. A comparative molecular field analysis (COMFA) of the structural determinants of heat-stable enterotoxins mediating activation of guanylyl cyclase C. J Med Chem. 2002 Apr 11; 45(8):1731-4. PMID: 11931628.
      View in: PubMed
    167. Ruiz-Stewart I, Kazerounian S, Pitari GM, Schulz S, Waldman SA. Soluble guanylate cyclase is allosterically inhibited by direct interaction with 2-substituted adenine nucleotides. Eur J Biochem. 2002 Apr; 269(8):2186-93. PMID: 11985597.
      View in: PubMed
    168. Kazerounian S, Pitari GM, Ruiz-Stewart I, Schulz S, Waldman SA. Nitric oxide activation of soluble guanylyl cyclase reveals high and low affinity sites that mediate allosteric inhibition by calcium. Biochemistry. 2002 Mar 12; 41(10):3396-404. PMID: 11876648.
      View in: PubMed
    169. Wolfe HR, Mendizabal M, Lleong E, Cuthbertson A, Desai V, Pullan S, Fujii DK, Morrison M, Pither R, Waldman SA. In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand. J Nucl Med. 2002 Mar; 43(3):392-9. PMID: 11884500.
      View in: PubMed
    170. Stone JA, Holland SD, Wickersham PJ, Sterrett A, Schwartz M, Bonfiglio C, Hesney M, Winchell GA, Deutsch PJ, Greenberg H, Hunt TL, Waldman SA. Single- and multiple-dose pharmacokinetics of caspofungin in healthy men. Antimicrob Agents Chemother. 2002 Mar; 46(3):739-45. PMID: 11850256.
      View in: PubMed
    Waldman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (498) concept(s)
    _
    Co-Authors Expand Description
    See all (36) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _